Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (215)

51

CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide

enthalten in: Haematologica | 2022

von Gurney, M. | Stikvoort, A. | Nolan, E. | +9

52

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma

enthalten in: Blood advances | 2021

von Frerichs, K. | Minnema, M. | Levin, M. | +11

53

Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence

enthalten in: Science translational medicine | 2021

von Katsarou, A. | Sjöstrand, M. | Naik, J. | +21

54

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies : the laboratory solution to eliminate interference

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Noori, S. | Verkleij, C. | Zajec, M. | +8

55

Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands : a population-based study

enthalten in: Blood cancer journal | 2021

von Brink, M. | Groen, K. | Sonneveld, P. | +10

56

Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Sonneveld, P. | Dimopoulos, M. | Beksac, M. | +37

57

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA) : an open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Moreau, P. | Hulin, C. | Perrot, A. | +49

CommentIn: Nat Rev Clin Oncol. 2021 Nov;18(11):676. - PMID 34545220

58

Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma

enthalten in: Journal of clinical medicine | 2021

von Hosny, M. | Verkleij, C. | van der Schans, J. | +4

59

Improving the identification of frail elderly newly diagnosed multiple myeloma patients

enthalten in: Leukemia | 2021

von Stege, C. | Nasserinejad, K. | Klein, S. | +26

60

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Stege, C. | Nasserinejad, K. | van der Spek, E. | +22